C-reactive protein and high mobility group box 1 in dogs with gastric dilatation and volvulus.

OBJECTIVE To (1) measure C-reactive protein (CRP) and high mobility group box 1 (HMGB1) and (2) evaluate their prognostic value and relationship to severity of systemic inflammatory response syndrome, routine hematological and acid-base parameters in dogs with gastric dilatation volvulus (GDV). DESIGN Prospective observational study from September 2010 to June 2012. SETTING Veterinary teaching hospital. ANIMALS Forty-one client-owned dogs with GDV. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Blood was collected before surgery (baseline), postsurgery, 6-10 hours postsurgery, and 18-22 hours postsurgery. CRP and HMGB1 were measured in all samples, and routine hematological, biochemical, and acid-base analyses were performed. Only baseline and postsurgery samples were used from nonsurvivors (n = 10). CRP increased significantly from postsurgery sampling to 18-22 hours postsurgery, while HMGB1 did not change over time. There was a significant difference in HMGB1 between survivors and nonsurvivors over time. Both proteins correlated with systemic inflammatory response syndrome severity, total leukocyte, segmented neutrophils, and band counts. HMGB1 correlated also with acid-base parameters (pH, bicarbonate, base excess). CONCLUSION HMGB1 and CRP behaved differently in regards to their kinetic patterns, with HMGB1 appearing to better reflect the severity of tissue injury in dogs with GDV than CRP.

[1]  Ju Huang,et al.  Relationship between plasma high-mobility group box-1 levels and clinical outcomes of ischemic stroke. , 2013, Journal of critical care.

[2]  K. Tatsch,et al.  Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients , 2013, International journal of cancer.

[3]  X. Dong,et al.  Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[4]  J. Suchodolski,et al.  Serum pepsinogen-A, canine pancreatic lipase immunoreactivity, and C-reactive protein as prognostic markers in dogs with gastric dilatation-volvulus. , 2012, Journal of veterinary internal medicine.

[5]  M. Lappin,et al.  Associations among albuminuria, C-reactive protein concentrations, survival predictor index scores, and survival in 78 critically ill dogs. , 2011, Journal of veterinary internal medicine.

[6]  H. Tsujimoto,et al.  Plasma high-mobility group box 1 (HMGB1) in dogs with various diseases: comparison with C-reactive protein. , 2011, The Journal of veterinary medical science.

[7]  J. Nemzek,et al.  High-mobility group box 1 as a surrogate prognostic marker in dogs with systemic inflammatory response syndrome. , 2010, Journal of veterinary emergency and critical care.

[8]  Elisabeth C R Snead,et al.  C-Reactive Protein as a Prognostic Indicator in Dogs with Acute Abdomen Syndrome , 2010, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[9]  J. Hirschberger,et al.  Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. , 2009, Journal of veterinary emergency and critical care.

[10]  C. Otto,et al.  The association between vascular endothelial growth factor levels and clinically evident peripheral edema in dogs with systemic inflammatory response syndrome. , 2009, Journal of veterinary emergency and critical care.

[11]  D. L. Chan,et al.  Relationship among plasma amino acids, C-reactive protein, illness severity, and outcome in critically ill dogs. , 2009, Journal of veterinary internal medicine.

[12]  A. Zeggwagh,et al.  Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units , 2008, Critical care.

[13]  C. Price,et al.  Association of canine obesity with reduced serum levels of C-reactive protein , 2008, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[14]  K. Tracey,et al.  The cytokine activity of HMGB1 , 2005, Journal of leukocyte biology.

[15]  H. Murua Escobar,et al.  Molecular characterization of the canine HMGB1 , 2003, Cytogenetic and Genome Research.

[16]  K. Tracey,et al.  Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.

[17]  K. Tracey,et al.  HMGB1 as a DNA‐binding cytokine , 2002, Journal of leukocyte biology.

[18]  J. Hauptman,et al.  Evaluation of the sensitivity and specificity of diagnostic criteria for sepsis in dogs. , 1997, Veterinary surgery : VS.

[19]  T. Fujinaga,et al.  Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. , 1994, The Journal of veterinary medical science.

[20]  P. Eckersall,et al.  C-reactive protein concentration in dogs with inflammatory leukograms. , 1994, American journal of veterinary research.

[21]  M. Pepys,et al.  C-reactive protein in dogs. , 1987, American journal of veterinary research.

[22]  R. Nakamura,et al.  Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. , 1976, American journal of clinical pathology.

[23]  H. Nakayama,et al.  A retrospective study in 21 Shiba dogs with chronic enteropathy. , 2011, The Journal of veterinary medical science.

[24]  Yan Yu,et al.  Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients. , 2011, Cytokine.

[25]  P. Nyström,et al.  The systemic inflammatory response syndrome: definitions and aetiology. , 1998, The Journal of antimicrobial chemotherapy.

[26]  J. Vilček,et al.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.